8-K: Atlantic American Corp Faces Nasdaq Delisting Over Delayed Filings
Notice of Delisting Determination
Atlantic American Corporation received a staff delisting determination from Nasdaq due to delayed periodic filings, prompting an appeal and a plan to regain compliance.
Summary
- Atlantic American Corporation (AAME) received a Staff Delisting Determination from Nasdaq on October 16, 2026.
- The determination was initiated because the company failed to file its 2025 Annual Report (10-K) and its Q1 and Q2 2026 Quarterly Reports (10-Q) by the extended deadline of October 12, 2026.
- This non-compliance violates Nasdaq Listing Rule 5250(c)(1).
- The company filed its 2025 Form 10-K on October 16, 2026.
- Atlantic American Corporation plans to appeal the determination by requesting a hearing before the Nasdaq Hearings Panel by October 23, 2026.
- A hearing request automatically stays delisting for 15 days, and the company will request a further stay pending the hearing process.
- Hearings are typically scheduled 30-45 days after the request.
- The company is working to file the remaining delinquent reports and regain compliance.
Sentiment
Score: 3
Explanation: StockSavvy.ai views this as a negative development due to the delisting determination, despite the company's efforts to rectify the situation.
Positives
- The company has filed its 2025 Form 10-K on October 16, 2026, addressing one of the delinquent reports.
- The company is actively working to file the remaining delinquent reports and regain compliance.
- The company intends to appeal the delisting determination and request a hearing, which provides an opportunity to rectify the situation.
- A hearing request automatically stays delisting for 15 days, providing a temporary reprieve.
- The company plans to present a detailed plan to the Nasdaq Hearings Panel to regain compliance.
Negatives
- The company received a Staff Delisting Determination from Nasdaq.
- The company is not in compliance with Nasdaq Listing Rule 5250(c)(1) due to failure to file required periodic reports.
- The company missed the extended deadline of October 12, 2026, for filing its 2025 Form 10-K and Q1/Q2 2026 Form 10-Qs.
- There is a risk that the Nasdaq Hearings Panel may not grant an extended stay, leading to suspension of trading.
- The company's common stock may be suspended from trading if an extended stay is not granted.
Risks
- The outcome of the company's appeal of the Staff Delisting Determination.
- The risk that the Nasdaq Hearings Panel will not grant the company's request for an extended stay or any additional extension period to regain compliance.
- Potential suspension of trading of the company's common stock on Nasdaq.
- Factors discussed in reports that the Company files from time to time with the SEC could impact future results.
Future Outlook
The company is working diligently to file the remaining delinquent reports and regain compliance with Nasdaq listing rules. The company intends to appeal the delisting determination and requests a stay pending the hearing process, but there is no assurance that the stay will be granted.
Management Comments
- The Company continues to work diligently, and is making progress, toward filing the remaining Delinquent Reports and regaining compliance with the Rule as promptly as practicable.
- The Company intends to appeal the Staff Determination by timely requesting a hearing before a Nasdaq Hearings Panel.
- The Company also intends to request that the suspension of trading be further stayed pending the hearing process.
- The Company intends to present to the Nasdaq Hearings Panel a detailed plan to regain compliance with the Rule.
Industry Context
StockSavvy.ai notes that Nasdaq has strict listing rules regarding timely financial reporting. Failure to comply can lead to delisting, which is a significant concern for investors as it can reduce liquidity and market visibility. Many companies face challenges in meeting these reporting deadlines, especially during periods of operational or financial stress.
Stakeholder Impact
- Shareholders: Potential for increased volatility and reduced liquidity if trading is suspended. Uncertainty regarding the company's ability to regain compliance and remain listed.
- Creditors: Increased risk due to the company's compliance issues and potential delisting, which could affect its financial stability.
- Employees: Potential impact on morale and job security if the company faces severe consequences from delisting.
Next Steps
- The company must request a hearing before the Nasdaq Hearings Panel by October 23, 2026.
- The company will request a stay of trading suspension pending the hearing process.
- The company will present a detailed plan to regain compliance to the Hearings Panel.
- The company aims to file the remaining delinquent reports as promptly as practicable.
Key Dates
| Date | Description |
|---|---|
| 2025-12-31 | Year ended December 31, 2025 (for the 2025 Form 10-K). |
| 2026-03-31 | Quarterly period ended March 31, 2026 (for a delinquent Form 10-Q). |
| 2026-06-30 | Quarterly period ended June 30, 2026 (for a delinquent Form 10-Q). |
| 2026-10-12 | Last day of the 180-day extension period granted by Nasdaq for the company to regain compliance. |
| 2026-10-16 | Date the Company received the Staff Delisting Determination from Nasdaq. |
| 2026-10-16 | Date the Company filed its 2025 Form 10-K with the SEC. |
| 2026-10-22 | Date of the press release announcing the Staff Delisting Determination. |
| 2026-10-23 | Deadline for the Company to request a hearing before the Nasdaq Hearings Panel. |
Recommendation
holdThe company is facing a significant risk of delisting due to delayed filings, which is a serious concern. However, they are actively addressing the issue by filing reports and planning an appeal. The outcome of the appeal and the ability to regain compliance are critical. A 'hold' recommendation reflects the uncertainty and the need to monitor the company's progress in resolving these compliance issues before considering a more definitive action.
Keywords
Delisting, Nasdaq, SEC Filings, Periodic Reports, Compliance, Appeal, Hearings Panel, Form 10-K
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.